@FiercePharma: Vets and pharma execs gather in DC to trade notes on pets in cancer research. FierceAnimalHealth story | Follow @FiercePharma
@CarlyHFierce: ICYMI: Valeant said to step up talks on potential $800M deal for Egypt's Amoun. Report | Follow @CarlyHFierce
> Peter Humphrey, who was just released from Chinese prison, said officials there withheld medical treatment to induce him to confess to a role in the GlaxoSmithKline ($GSK) bribery scandal. Report
> Novartis' ($NVS) generics unit Sandoz asked the Mississippi Supreme Court to overturn a $38.2 million judgment in a Medicaid drug-pricing suit. Report
> Bayer HealthCare will halt production at a plant in St. Joseph, MO, next week, after announcing earlier this year that the 120-employee facility would close. Report
> Multinational drugmakers are amping up their over-the-counter drug business in China as provincial governments squeeze prices for prescription drugs. Report
Medical Device News
@FierceMedDev: FDA approves Roche's companion diagnostic for Pfizer's non-small cell lung cancer med. More from FierceDiagnostics | Follow @FierceMedDev
@VarunSaxena2: ICYMI: HeartWare, hit with its fifth Class 1 recall of 2015, will replace defective blood pump controllers. Report | Follow @VarunSaxena2
@EmilyWFierce: Shire, Sanofi and Bayer have the best public reps in pharma. FiercePharma report | Follow @EmilyWFierce
> After 2014 IPO and recent take-out rumor, medical laser player Lumenis ($LMNS) to be acquired for $510M. Story
> Medtronic ($MDT) buys into Arsenal, gets option to purchase the post-surgical foam startup subsidiary. Article
Biotech News
@FierceBiotech: ICYMI yesterday: Synergy soars on stellar constipation data, rekindling buyout chatter. Article | Follow @FierceBiotech
@JohnCFierce: BioMarin shines as dwarfism drug boosts growth in children. News | Follow @JohnCFierce
@DamianFierce: ICYMI: And hey $AGN's spending $2.1B on $KYTH and its chin-fat-reducing injection. Article | Follow @DamianFierce
> Woodford exits Sanofi ($SNY), doubles down on Circassia in portfolio rejig. More
> BioMarin ($BMRN) shines as dwarfism drug boosts growth in children. News
> Merck KGaA hustling a promising anti-malaria drug into human studies. Article
> Medigene files to raise €50M to hit gas on T-cell R&D programs. Report
Vaccines News
> Merck ($MRK), GSK, Sanofi and Pfizer ($PFE) will vie for crown in tight vaccines race by 2020: Report. More
> When it comes to a MERS vaccine, for Big Pharma, the money's not there yet. More
> Merck, Sanofi granted European Commission thumbs-up on Gardasil 9. Story
> Ebola vaccines left hanging as GSK, Merck, J&J ($JNJ) scramble for trial volunteers. Article
> Move over, India--China can make WHO-approved vaccines, too. Report
CRO News
> Quintiles ($Q) beefs up its risk-based monitoring tech. Report
> Veristat reaches into the Bay Area with new outpost. Item
> AMRI ($AMRI) recruits PerkinElmer ($PKI) to build out a new R&D hub. Article
> GVK inks a deep biotech deal as it rebuilds its reputation. News
> PPD partners up for real-world outcomes research. Story
Pharma Manufacturing News
> Sun purges 18 Ranbaxy execs in integration move. Item
> Geri-Care buiding second plant in Mississippi. More
> Lonza building viral therapies plant in Texas. News
> Thermo Fisher ($TMO) putting $22M into new plant in Scotland. Article
> Ukraine drugmaker opens $40M plant in Kyiv. Report
Pharma Asia News
> A heavier China drives cardio, diabetes and healthcare reforms. Item
> India's Strides-Shasun merger hits roadblock over shareholding structure. More
> China FDA ahead for UCB's Neupro after PhIII Parkinson's results. Story
> Emerging markets, Advair generic the trick as India's Cipla eyes growth. Article
> Researchers say compound stops transmission of malaria parasite in mice. Report
And Finally... England's National Health Service proposed using wearable technology to monitor hospital patients. Report